Tech Company Financing Transactions
Cyterix Pharmaceuticals Funding Round
Cyterix Pharmaceuticals secured a $9.2 million Series A funding round on 6/8/2011. Investors included SV Health Investors and The Column Group.
Transaction Overview
Company Name
Announced On
6/8/2011
Transaction Type
Venture Equity
Amount
$9,200,000
Round
Series A
Investors
SV Health Investors (Lutz Giebel)
The Column Group (Timothy Kutzkey)
Proceeds Purpose
Continuing in our cash-efficient business model, we expect these funds to advance our two lead compounds through IND-enabling studies, as well as further expand the development of our technology platform and our exploration of new targets within the extra-hepatic cytochrome P450 enzyme family.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1700 Owens St. 500
San Carlos, CA 94158
USA
San Carlos, CA 94158
USA
Phone
Website
Email Address
Overview
Cyterix Pharmaceuticals, Inc., a privately held cancer therapeutics company, is engaged in the discovery and development of new classes of small molecule prodrugs with improved safety and efficacy over traditional drugs.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Steven Everett
Chief Financial Officer
Luis Bayol
VP - Human Resources
Chris Smith
Browse more venture capital transactions:
Prev: 6/8/2011: Pawngo venture capital transaction
Next: 6/8/2011: SeaMicro venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC transactions reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs